CompletedNot Applicable

Educate, Assess Risk and Overcoming Barriers to Colorectal Screening Among African Americans

United States163 participantsStarted 2019-02-27

Plain-language summary

The burden of colorectal cancer (CRC) is unequal among various populations within the United States. This inequality is most notable among African Americans, who exhibit the highest CRC mortality of all US populations. This study aims to evaluate a community-based intervention to educate, assess risk, and overcome barriers to screening among African Americans who are 45 years or older with no personal history of CRC, adenomas, or inflammatory bowel disease and have no family history of CRC. Barriers being assessed include: Need for establishing care with primary care physician, need for financial assistance, need for reminder calls, need for transportation, need for appointment coordination, and need for education about colonoscopy preparation and procedure

Who can participate

Age range18 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Education Only: African American individuals 18 years and older. * CRC colonoscopy screening : Average Risk African American individuals ages 45 - 75 who did not have a screening colonoscopy or other screening modality within the past10 years, have no history of CRC, adenomatous polyps or Inflammatory Bowel Disease (IBD) and no family history of colorectal cancer. This will be identified during outreach events (steps 3 and 4). * It is important to note that this program may ultimately include all races as a community outreach event, however we will not analyze the data of non-African Americans. Exclusion Criteria: * African American individuals under the age of 18 * Colonoscopy within 10 years * History of CRC, Adenoma, IBD * Family history of CRC * Fecal immunochemical test (FIT) within the past year * Cologuard test within the past 3 years * Flexible Sigmoidoscopy test within the past 5 years * Colonography within the past 5 years

What they're measuring

Difference in paired pre-/post-test score

Timeframe: From baseline (week 0) to follow-up end of study (week 24)

Trial details

NCT IDNCT03640208

SponsorCase Comprehensive Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11-03